- Terumo Cardiovascular and CytoSorbents Collaborate to Commercialize CytoSorb® in Ten U.S. Hotspot States under Emergency Use Authorization for COVID-19
(August 24, 2020)
- Use of Terumo Cardiovascular’s CDI Blood Parameter Monitoring Systems in Extracorporeal Membrane
Oxygenation Therapy (April 20, 2020)
Reinforcing our commitment to delivering cardiovascular technologies to improve patient care.
Whether you are a novice or expert harvester, Terumo’s Advanced EVH training program can benefit you.